Hexachlorobenzene (HCB) and dichlorodiphenyltrichloroethane (DDT) are organochlorines (OCs) used in fungus and pest control. These OCs have demonstrated estrogenic activity in *in vitro* assays and adverse reproductive effects in fish and wildlife ([@r28]). Although HCB and DDT have been banned in the United States, HCB is a by-product of organic chemical production processes and is still produced outside the United States \[Agency for Toxic Substances and Disease Registry (ATSDR) 2002b\]. DDT continues to be used abroad for the control of mosquito-borne diseases ([@r31]).

The main source of human exposure to these OCs is through dietary ingestion. Generally, HCB and DDT are found in meat, fish, and milk products ([@r4]; [@r6]; [@r21]; [@r33]). DDT can be found in higher concentrations in foods imported from countries still using DDT (ATSDR 2002a). Because of their chemical stability, bioaccumulation up the food chain, and the ongoing production or use in some countries, HCB, DDT, and dichlorodiphenyldichloroethylene (DDE), the primary metabolite of DDT, continue to be detected in human blood (ATSDR 2002a), breast milk ([@r29]), follicular fluid ([@r22]), amniotic fluid ([@r7]; [@r19]), and human umbilical cord blood ([@r13]).

There are conflicting data regarding the effect of exposure to DDT/DDE on early reproductive outcomes. A recent study described no association between oocyte, fertilization, and implantation parameters in women undergoing *in vitro* fertilization (IVF) and exposure to DDT ([@r1]). Another study found an association between increased time to pregnancy and self-report of exposure to agricultural and home pesticides ([@r9]). Some studies suggest an association of DDT/DDE with early clinically detected fetal loss ([@r18]; [@r32]). Other studies reported early pregnancy loss and early neonatal and childhood mortality after a widespread accidental exposure to HCB in Turkey ([@r11]; [@r24]). Because of concerns raised by these earlier studies, we explored the association of serum levels of these persistent OCs with early reproductive failure uniquely observable within the context of an IVF study.

Methods
=======

*Study population.* This study population is a nested case--control subset of patients derived from a prospective cohort designed to assess predictors of IVF outcomes. Between August 1994 and June 2003, couples commencing assisted reproduction therapy were enrolled through three Boston, Massachusetts, area clinics. Couples agreeing to participate in this study underwent an informed consent process and provided written consent before enrollment. There were two phases of patient enrollment, 1994--1999 and 2000--2003, corresponding to initial funding and renewal phases. Study protocols were approved by the Institutional Review Board at Brigham and Women's Hospital and the Human Subjects Committee at Harvard School of Public Health. Approximately 65% of couples who were approached agreed to participate in the study. Couples who required donor gametes, a gestational carrier, or gamete/zygote intrafallopian transfer were excluded from the main study. Most couples underwent multiple IVF cycles (up to six), with an average of two cycles per couple.

Because of budget limitations, we were unable to measure serum OC levels on all of the study participants. Therefore, we devised our case and control selection strategy to maximize statistical power, selecting cases based on outcomes of interest. Of the 2,350 couples in the main study, 765 women were selected by the outcome of their first IVF cycle (failed implantation, chemical pregnancy, spontaneous abortion, or live birth). Because the number of available cases varied by failure type, with failed implantation being most frequent, we analyzed serum HCB/DDT/DDE concentrations for a random sample of 200 women with first-cycle implantation failures. Because chemical pregnancies and spontaneous abortions were less frequent, all cycles from the entire cohort with these outcomes were selected. Also included in the analysis were 62 repeated cycles among a subset of 46 women, from a total of 265 cycles from 110 women who were selected for measurement of DDE, DDT, and HCB in a prior analysis of within-woman variability in serum concentrations of OC compounds from the same parent study ([@r22]). A corresponding sample of first-cycle live births was selected using stratified sampling based on age category, study center, and study phase. In total, 765 women contributed 827 cycles.

Data abstracted from clinical records were infertility diagnoses, ovarian stimulation protocol (down-regulation or flare), type and total ampules of gonadotropin, use of intracytoplasmic sperm injection (ICSI), day of embryo transfer (ET), number of embryos transferred, and cycle outcomes.

Only women who proceeded to undergo ET of one or more embryos were eligible for the present analysis. When at least one embryo was transferred but without subsequent rise of human chorionic gonadotropin (hCG) beyond 5.0 mIU/mL, the cycle outcome was defined as a failure of implantation. A chemical pregnancy was defined by a post-ET hCG measurement of ≥ 5.0 mIU/mL with no further embryonic development (gestational sac or yolk sac). Clinical pregnancy was determined by ultrasound visualization of a gestational sac or a fetal heartbeat. Among clinically recognized pregnancies, outcomes included spontaneous abortion (fetal demise before 20 weeks of gestation) or live birth of at least one infant. Other outcomes for clinically recognized pregnancy were ectopic pregnancy, molar pregnancy, and stillbirth (fetal demise at ≥ 20 gestational weeks) and were excluded in the present analysis because numbers were small and lacked power for independent investigation.

*Measurement of HCB, DDT, and DDE in serum.* Blood samples were collected from women during the follicular phase of their first IVF/ICSI cycle and subsequent cycles in a nonfasting state immediately before hCG administration. The serum fraction was separated for all blood samples by centrifugation and stored at --80°C. Measurement of the OC pesticides HCB, *p*,*p*´-DDT, *p*,*p*´-DDE, *o*,*p*´-DDT, and *o*,*p*´-DDE was conducted by the Organic Chemistry Analytical Laboratory, Harvard School of Public Health (Boston, MA), using methods described previously ([@r16]). Briefly, after liquid--liquid extraction and column chromatography, samples were analyzed by dual gas chromatography with electron capture detection, on two capillary columns of different polarity using two internal standards. Samples were accompanied by the following quality control samples: a procedural blank, matrix spike samples, and a laboratory control sample. Each sample was spiked with two surrogate compounds to monitor the efficiency of the extraction procedure. All final results were reported after subtracting the amount of the analyte measured in the procedural blank associated with the analytic batch. Method detection limits (MDLs) were determined as recommended by the U.S. Environmental Protection Agency (1984).

The wet-weight MDL values for HCB and congeners of DDT and DDE were all \< 0.01 ng/g. The OC concentrations were measured at part per billion concentrations. The within-assay variation for all target pesticides ranged from 2% to 5%. The between-assay variation (percent coefficient of variation) for all target pesticides was \< 10%.

Serum total cholesterol and triglycerides were measured enzymatically. Total serum lipid content was calculated by Equation 2 of [@r25] and then used for lipid standardization of serum OC concentration.

*Statistical analysis.* Serum OC concentrations in the study population of 765 women were grouped into quartiles (Q1--Q4). Total DDT was defined for this analysis as a sum of *p*,*p*´-DDT, *o*,*p*´-DDT, *p*,*p*´-DDE, and *o*,*p*´-DDE. The relation between IVF outcomes and quartiles of HCB, *p*,*p*´-DDE, and total DDT was explored with multivariable generalized linear regression models, with data structured to accommodate joint models for multiple outcomes and multiple cycles contributed per woman. Whenever a woman was at risk of a cycle failure because of implantation failure, chemical pregnancy, or spontaneous abortion in each cycle, a binary outcome (1 = failure, 0 = not a failure) was recorded. Thus, a woman provided up to three contributions to risk sets for the possible outcomes within each IVF cycle. A logistic regression model was then employed for each early pregnancy outcome, while adjusting for covariates. Interaction terms between OC quartile and failure type were included in the model to allow for a distinct relation between the OC of interest and reproductive failure type. Interaction terms between age and failure type were also included to account for the possibility of differing age effects on the various failure end points. A woman-specific random-effect term, assumed to be Gaussian, was included to account for the correlation among outcomes from different cycles for the same woman. Trend tests were conducted by assigning ordinal integer values to HCB, DDE, and DDT quartiles (0 = Q1 to 3 = Q4).

Potential confounding variables considered in our analyses were maternal age (\< 35, 35--37, 38--40, \> 40 years), body mass index (BMI), serum lipids, smoking status (never, past, or current), site (of the three participating Boston area clinics), study phase (1994--1998 or 1999--2003), race (Caucasian or other), previous live birth (yes/no), ampules of gonadotropins, protocol (down-regulation or other), ICSI (yes/no), number of embryos transferred, and primary infertility diagnosis. Primary infertility diagnoses were categorized as male factor, ovulatory dysfunction, and other/unexplained. The "other/unexplained" category included Müllerian anomalies and uterine or tubal pathology. Cycles that were missing race, infertility diagnosis, or previous live birth (6% of cycles) were assigned a missing indicator variable and retained in all analyses. Cycles missing any other covariate information were excluded.

The serum OC concentrations were standardized by dividing by the calculated total serum lipid concentration. In addition, we also modeled IVF outcomes in relation to wet-weight serum levels of the specific and adjusted for serum lipids as a covariate in multivariable models, to reduce bias, as suggested by [@r27].

Data analysis was conducted using SAS software (version 9.1; SAS Institute Inc., Cary, NC). *p*-Values \< 0.05 were considered statistically significant.

Results
=======

Of the 827 IVF cycles evaluated, 774 (94%) had sufficient covariate information to be included in our analysis, representing 720 (94%) of the 765 women. Among the 54 IVF cycles excluded, 6 were missing BMI, 13 were missing lipids, 2 were missing ampules of gonadotropins, and 32 were missing number of embryos transferred. The 720 women had a mean age of 35 years, were primarily Caucasian (90%) and current nonsmokers (94%), and had a mean BMI of 24.2 kg/m^2^ ([Table 1](#t1){ref-type="table"}). Unexplained infertility (34%) and male factor (35%) accounted for most infertility diagnoses; the remaining women were diagnosed with either tubal factor (18%) or ovulatory dysfunction (13%). Because of the nested case--control sampling design, the oversampling of failure outcomes on a subset of women was not representative of the failure outcome percentages of the main study. There were 541 total cycle failures, of which 490 were included in the analysis and consisted of implantation failure (209), chemical pregnancy (161), and spontaneous abortion (120).

###### 

Characteristics of all women undergoing IVF eligible for inclusion in the analytic population (*n* = 765) and women included in the final model (*n* = 720).

  Characteristic                                                                                All (765 women, 827 cycles)   Included (720 women, 774 cycles)      
  --------------------------------------------------------------------------------------------- ----------------------------- ---------------------------------- -- -------------
  Age (years)                                                                                                                 35.9 ± 4.21                           35.4 ± 4.20
  BMI (kg/m^2^)                                                                                                               24.2 ± 5.09                           24.2 ± 5.12
  Caucasian                                                                                                                   693 (90.6)                            651 (90.4)
  Cigarette smoking status                                                                                                                                          
  Current smoker                                                                                                              50 (7)                                40 (6)
  Past smoker                                                                                                                 223 (29)                              214 (30)
  Previous live birth                                                                                                         181 (24)                              171 (24)
  Total gonadotropins (mIU)*a*                                                                                                34.4 ± 18                             34.4 ± 18
  Down-regulation stimulation protocol*a*                                                                                     604 (73)                              569 (74)
  ICSI*a*                                                                                                                     259 (31)                              245 (32)
  No. of embryos transferred*a*                                                                                               3.15 ± 1.33                           3.16 ± 1.33
  Serum lipids (mg/g)                                                                                                         5.12 ± 1.13                           5.22 ± 1.17
  Infertility diagnosis*b*                                                                                                                                          
  Tubal factor                                                                                                                143 (19)                              129 (18)
  Ovulatory dysfunction                                                                                                       99 (13)                               92 (13)
  Male factor                                                                                                                 267 (35)                              251 (35)
  Unexplained                                                                                                                 256 (34)                              248 (34)
  IVF outcome*a*                                                                                                                                                    
  Failed implantation                                                                                                         229 (28)                              209 (27)
  Chemical pregnancy                                                                                                          177 (21)                              161 (21)
  Spontaneous abortion                                                                                                        124 (15)                              120 (16)
  Other (ectopic/stillbirth/molar pregnancy)                                                                                  11 (1)                                10 (1)
  Live birth                                                                                                                  286 (35)                              274 (35)
  Values are mean ± SD or *n* (%). **a**Cycle-level data. **b**Primary infertility diagnosis.                                                                       

Distributions of serum concentrations of HCB, DDT, and DDE are presented as both wet-weight and lipid-standardized concentrations ([Table 2](#t2){ref-type="table"}). No samples were below the limit of detection. The geometric mean (GM) and median concentration for HCB were 0.088 and 0.087 ng/g serum, respectively, compared with a GM and median of 0.095 and 0.092 ng/g serum in the general U.S. female population in 2003--2004 \[Centers for Disease Control and Prevention (CDC) 2009\]. Total DDT had the highest concentration (median = 1.12 ng/g serum, range 0.02--31.8 ng/g serum). Most of the total DDT was from *p*,*p*´-DDE contributions, which accounted for \> 90% of the sum of all measured DDT/DDE congeners. The GM and median *p*,*p*´-DDE concentrations were, respectively, 1.09 and 1.04 ng/g serum, with a range of 0.007--30.6 ng/g serum, compared with a GM and median of 1.45 and 1.25 ng/g serum in the general female U.S. population ([@r5]). The GM and median for *p*,*p*´-DDT in the general female U.S. population included levels below the limit of detection ([@r5]). There was a strong correlation between the concentration of total DDT and *p*,*p*´-DDE (Spearman correlation coefficient = 0.98). Of the 46 women with serum from multiple cycles ultimately included in the final analysis, 29 (63%) remained in the same HCB quartile across cycles after lipid standardization, similar to the 34 (71%) with lipid adjustment in the multivariable model. HCB concentrations between cycles were also strongly correlated (Spearman correlation coefficient = 0.98).

###### 

Distribution of serum HCB, *p*,*p*´-DDE, and total DDT concentrations among 765 women undergoing IVF.

  OC                                                                                               GM   Minimum   Q1 (mean)   Median   Q3 (mean)   Maximum                            
  ------------------------------------------------------------------------------------------------ ---- --------- ----------- -------- ----------- --------- -- ------- -- ------- -- -------
  Wet weight (ng/g serum)                                                                                                                                                             
  HCB                                                                                                   0.088                 0.005                0.066        0.087      0.114      2.31
  *p*,*p*´-DDE                                                                                          1.09                  0.007                0.659        1.04       1.75       30.6
  Total DDT*a*                                                                                          1.22                  0.020                0.741        1.12       1.88       31.8
  Lipid standardized (ng/g lipid)                                                                                                                                                     
  HCB                                                                                                   18                    3.39                 13.3         17.5       23.0       426
  *p*,*p*´-DDE                                                                                          226                   26.1                 132          210        362        6,627
  Total DDT*a*                                                                                          251                   31.7                 148          233        390        6,977
  **a**Total DDT includes the sum of *p*,*p*´-DDT, *o*,*p*´-DDT, *p*,*p*´-DDE, and *o*,*p*´-DDE.                                                                                      

When serum lipids were adjusted as a covariate with other potential confounders, a dose--response relation between increasing HCB concentration quartile and odds ratios (ORs) for failed implantation was observed ([Table 3](#t3){ref-type="table"}). Compared with women in Q1, the multivariable adjusted ORs for failed implantation were 1.71 for women in Q2 \[95% confidence interval (CI): 1.03, 2.82\], 2.30 for women in Q3 (95% CI: 1.39, 3.81), and 2.32 for women in Q4 (95% CI: 1.38, 3.90; *p*-value, test for linear trend = 0.001). When lipid-standardized HCB concentrations were used as the dependent variable, a statistically significant linear increase in ORs for implantation failure remained. Although no statistically significant associations were found between serum HCB and chemical pregnancy, spontaneous abortion, or early pregnancy failure, ORs for early pregnancy failure increased with increasing HCB quartiles. Lack of statistical significance may be due to the relatively small numbers of chemical pregnancies and spontaneous abortions.

###### 

Adjusted ORs*^a^* and 95% CIs for cycle outcomes in relation to serum HCB quartiles among 720 women undergoing IVF.

  Models with HCB concentrations standardized by serum lipids (g)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Models adjusted for serum lipids (ng/g) as a covariate*b*                                                                    
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ----------------------------------------------------------- ----- ----- ----- -- ------------------- -- ----- ----- ----- -- -------------------
  Failed implantation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
  Q1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 189   204   38       Referent               197   209   41       Referent
  Q2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 181   203   48       1.33 (0.82, 2.15)      188   208   55       1.71 (1.03, 2.82)
  Q3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 192   204   65       1.81 (1.11, 2.95)      191   208   67       2.30 (1.39, 3.81)
  Q4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 191   203   75       2.31 (1.42, 3.77)      195   208   71       2.32 (1.38, 3.90)
  *p*~trend~                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              \< 0.001                                    0.001
  Chemical pregnancy                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
  Q1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 189   204   47       Referent               197   209   42       Referent
  Q2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 181   203   41       0.86 (0.52, 1.44)      188   208   45       1.14 (0.70, 1.91)
  Q3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 192   204   45       1.30 (0.77, 2.18)      191   208   44       1.43 (0.84, 2.44)
  Q4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 191   203   41       1.07 (0.62, 1.85)      195   208   46       1.35 (0.78, 2.34)
  *p*~trend~                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              0.49                                        0.20
  Spontaneous abortion                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                
  Q1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 189   204   32       Referent               197   209   35       Referent
  Q2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 181   203   34       1.07 (0.59, 1.95)      188   208   32       1.06 (0.57, 1.93)
  Q3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 192   204   31       1.40 (0.74, 2.66)      191   208   28       1.12 (0.59, 2.13)
  Q4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 191   203   25       1.08 (0.55, 2.10)      195   208   29       1.23 (0.64, 2.35)
  *p*~trend~                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              0.59                                        0.52
  Early pregnancy failure                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
  Q1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 189   204   118      Referent               197   209   119      Referent
  Q2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 181   203   123      1.11 (0.73, 1.70)      188   208   134      1.38 (0.89, 2.13)
  Q3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 192   204   147      1.96 (1.22, 3.14)      191   208   144      1.91 (1.20, 3.02)
  Q4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 191   203   145      1.81 (1.11, 2.96)      195   208   149      1.98 (1.19, 3.28)
  *p*~trend~                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              0.003                                       0.003
  **a**Joint models for multiple outcomes and multiple cycles per woman were adjusted for serum lipids, study site, study phase, race/ethnicity, previous live birth, maternal age, BMI, smoking status, ampules of gonadotropins, protocol, ICSI, number of embryos transferred, and primary infertility diagnosis. **b**Wet-weight serum (ng/g serum) measurements were used to assign quartiles, followed by lipid adjustment (g lipid/g serum) using lipid as a covariate in the model; 66% of the cycles had a lipid-adjusted HCB value in the same quartile as the lipid-standardized HCB value.                                                                                                                                

Although no statistically significant associations were found between *p*,*p*´-DDE and any individual or combined early reproductive failures, the OR for any of the three early pregnancy failure types among cycles in Q4 *p*,*p*´-DDE versus Q1 was 1.6 (95% CI: 0.98, 2.63) ([Table 4](#t4){ref-type="table"}). The OR for Q4 total DDT, after lipid adjustment, and early pregnancy failure versus Q1 was 1.85 (95% CI: 1.13, 3.03; *p*-value, test for linear trend = 0.049; data not shown).

###### 

Adjusted ORs*^a^* and 95% CIs for cycle outcomes in relation to serum *p*,*p*´-DDE quartiles among 720 women undergoing IVF.

  Outcome/DDE quartile                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Models with *p*,*p*´-DDE concentrations standardized by serum lipids (g)   Models adjusted for serum lipids (ng/g) as a covariate*b*                                                              
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------------------------------------------------- ----------------------------------------------------------- ----- ----- -- ------------------- -- ----- ----- ----- -- -------------------
  Failed implantation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
  Q1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     188                                                         204   48       Referent               195   209   54       Referent
  Q2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     184                                                         203   52       0.98 (0.61, 1.56)      187   208   56       1.16 (0.72, 1.86)
  Q3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     187                                                         204   65       1.17 (0.73, 1.86)      193   208   61       1.12 (0.70, 1.81)
  Q4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     194                                                         203   61       1.14 (0.70, 1.83)      196   208   63       1.19 (0.73, 1.94)
  *p*~trend~                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        0.29                                        0.56
  Chemical pregnancy                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
  Q1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     188                                                         204   43       Referent               195   209   43       Referent
  Q2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     184                                                         203   45       1.19 (0.72, 1.98)      187   208   40       1.09 (0.64, 1.87)
  Q3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     187                                                         204   41       1.16 (0.68, 1.96)      193   208   45       1.14 (0.67, 1.81)
  Q4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     194                                                         203   45       1.19 (0.70, 2.03)      196   208   49       1.36 (0.78, 1.94)
  *p*~trend~                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        0.56                                        0.30
  Spontaneous abortion                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          
  Q1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     188                                                         204   30       Referent               195   209   30       Referent
  Q2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     184                                                         203   32       1.21 (0.66, 2.22)      187   208   32       1.02 (0.55, 1.93)
  Q3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     187                                                         204   22       0.62 (0.33, 1.18)      193   208   24       0.67 (0.34, 1.30)
  Q4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     194                                                         203   38       1.40 (0.74, 2.65)      196   208   38       1.33 (0.69, 2.56)
  *p*~trend~                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        0.67                                        0.70
  Early pregnancy failure                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       
  Q1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     188                                                         204   124      Referent               195   209   130      Referent
  Q2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     184                                                         203   131      1.16 (0.76, 1.79)      187   208   129      1.08 (0.70, 1.65)
  Q3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     187                                                         204   129      0.96 (0.62, 1.47)      193   208   133      1.03 (0.67, 1.59)
  Q4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     194                                                         203   149      1.52 (0.94, 2.44)      196   208   154      1.61 (0.98, 2.63)
  *p*~trend~                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        0.12                                        0.09
  **a**Joint models for multiple outcomes and multiple cycles per woman were adjusted for serum lipids, study site, study phase, race/ethnicity, previous live birth, maternal age, BMI, smoking status, ampules of gonadotropins, protocol, ICSI, number of embryos transferred, and primary infertility diagnosis. **b**Wet-weight serum (ng/g serum) measurements were used to assign quartiles, followed by lipid adjustment (g lipid/g serum) using lipid as a covariate in the model.                                                                                                                                                                                                     

We additionally evaluated the relations of serum wet-weight concentrations of DDE, DDT, and HCB, without lipid adjustment or lipid standardization, and outcomes, and effect estimates were altered negligibly (data not shown).

Discussion
==========

Among the 765 women undergoing IVF in this study, all had detectable serum levels of HCB, DDT, and DDE. Implantation failure ORs exceeded 2 for women with serum concentrations of HCB in Q4, compared with women in the lowest quartile. Previous studies within this cohort have shown that serum OC concentrations were strongly correlated with follicular fluid concentrations (*r*-values: HCB, 0.66; *p*,*p*´-DDE, 0.92; *p*,*p*´-DDT, 0.74) ([@r22]), and in other populations OCs were detectable in amniotic fluid ([@r7]), suggesting the possibility of direct gamete and embryo exposure.

We are not aware of another study that describes the association between clinically observed implantation failure and exposure to HCB; therefore, it will be critical that further studies by other investigators replicate this finding. However, a nonhuman primate study demonstrated that HCB exposure induced a dose-dependent suppression of luteal serum progesterone ([@r8]). Suppressed luteal progesterone may increase the likelihood of implantation failure due to reduced endometrial maturation or of early pregnancy loss from inadequately low levels of progesterone production ([@r15]). Other studies demonstrated that HCB exposure was associated with degenerative changes in ovarian structure, including germ cell destruction in rhesus monkeys ([@r10]) and primordial germ cell loss in cynomolgus monkeys ([@r12]), suggesting other potential mechanism of impaired reproductive outcome.

Our study did not find a statistically significant association between HCB and chemical pregnancy or spontaneous abortion. However, exposure to HCB-contaminated foods in Turkey between 1955 and 1957 resulted in detectable HCB in serum drawn 40 years later. In that population, higher HCB levels were associated with a self-reported history of spontaneous abortion ([@r11]). Furthermore, time to pregnancy, a possible surrogate marker for implantation failure, was not assessed in that study.

In the present study, we also found no significant association between serum DDT/DDE and implantation failure, chemical pregnancy, or early pregnancy loss. However, we did observe a nonsignificant OR of 1.6 for any of the three early pregnancy failure types among cycles in *p*,*p*´-DDE Q4 compared with those in Q1.

One study that evaluated serum DDE levels among 1,717 women and assessed past pregnancy outcomes via survey found a significant adjusted OR of 1.4 (95% CI: 1.1, 1.6) for fetal loss in women per 60-µg/L increase of serum DDE ([@r18]). The primary limitation of that study was the retrospective design in which current serum DDE concentrations were associated with past fetal loss. Another study that followed newly married female textile workers in China also found an association between serum total DDT (range, 5.5--113.3 ng/g serum; median, 27.9 ng/g) and subsequent early fetal loss, defined as \< 6 weeks of gestation as measured through decline in urinary hCG ([@r32]). In a smaller study with 99 women undergoing their first cycle of IVF, no statistically significant relationships between serum and follicular concentrations of DDT/DDE and oocyte number, quality, fertilization rates, or pregnancy rates were reported, although serum DDT/DDE concentrations were higher than in our study population. The authors suggested that some "statistically suspicious" associations were observed; however, ORs, CIs, and *p*-values were not given ([@r14]).

One limitation of the present study is that the study population consisted of couples undergoing IVF. It is unknown whether infertile couples respond differently to OC exposure relative to fertile couples or women with untested fertility. Therefore, although the results of this study are internally valid, it is unclear whether the associations of between HCB or DDE/DDT and early pregnancy outcomes would differ among women who have never experienced infertility. However, in the spontaneous conception setting, it would not be possible to evaluate the association between these OC exposures and implantation failure because it is currently unobservable. The second limitation is that serum concentrations were available only for females and not their male partners. However, exposures to certain ubiquitous chemicals have been shown to be correlated within couples undergoing IVF ([@r20]). Certain predictors of serum OC concentration were not available for this analysis, such as past breast-feeding history and country of origin. However, most patients were likely to be of American origin; other known predictors of persistent pesticide exposure were included in our models, including age and smoking.

Finally, the serum sample from which OC concentration and lipid content were quantified was not a fasting sample. Although both lipid content and serum wet weight of OC increase after a meal, they do not increase proportionally. Furthermore, the method chosen for lipid correction does affect the final corrected concentration. The equation used in our study to calculate total lipids was chosen from those suggested by [@r25] and accounts for total cholesterol and triglycerides but does not diminish the differences between fasting and nonfasting lipid profiles. However, when lipids are accounted for, there are data to suggest that there still is a high degree of correlation between a fasting and nonfasting serum sample (0.96) ([@r17]).

Our study had a number of strengths. The prospective cohort from which this nested case--control study population was drawn employed risk set sampling that allowed for collection of questionnaire data and biological samples before the cycle outcome and temporally close to the clinically and biologically relevant outcomes of interest. In addition, our analyses applied advanced statistical methodology that validly accommodated inclusion of data from multiple cycle outcomes per woman and time-varying exposures and potential confounders. The assessment of early reproductive end points observable only during the IVF process allows for insight into critical points in early pregnancy.

The HCB levels in the study population were close to but generally lower than those of the adult female U.S. population ([@r5]). Additionally, levels of DDT/DDE observed within Q4 among the women in our study population were lower than those of the general populations of many Asian and African countries where DDT is still in use ([@r5]; [@r23]; [@r26]). Therefore, relations observed within our study population may be estimating the association of these OCs only within the lower tail of the international exposure distribution. Further studies in the general U.S. population and in countries with high pesticide burdens are needed.

Conclusion
==========

We found significantly greater odds of implantation failure in relation to serum HCB levels. Persistent organic chemicals, despite banned use within the United States, may have an adverse impact on conception and pregnancy progression. Couple-based exposure assessment and study of the adverse effects on gametes, endometrium, and embryo development are needed so that these risks can be better understood.
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